Lixin Jason Wang from 4200 Balboa Ct, Arlington, TX 76016, age 57, Phone: (817)9172659

Resumes

Medical Director, Ophthalmology

view source

Location:

Houston, TX

Industry:

Pharmaceuticals

Work:

Novartis
Medical Director, Ophthalmology
Alcon, A Novartis Company
Senior Clinical Lead, Global Clinical Development and Medical Affairs
Alcon, A Novartis Company Jul 2013 - Oct 2015
Assistant Director, Surgical Iol R and D
Alcon, A Novartis Company Jan 2011 - Aug 2013
Head, Surgical Sciences, Iol R and D and Principal Scientist and Project Head
Alcon, A Novartis Company Feb 2009 - Jan 2011
Senior Research Scientist Iii and Project Lead

Education:

University of East Anglia 2000 - 2004
Doctorates, Doctor of Philosophy, Philosophy Harbin Medical University 1987 - 1992
Doctor of Medicine, Doctorates

Skills:

Medical Devices
R&D
In Vivo
In Vitro
Biotechnology
Pharmaceutical Industry
Ophthalmology
Drug Development
Molecular Biology
Clinical Development
Biochemistry
Drug Discovery
Cell Culture
Cell Biology
Surgical Instruments
Lifesciences
Life Sciences
Cataract
Cell
Research and Development
Medical Affairs
Medical Writing

Lixin Wang

view source

Lixin Wang

view source

Lixin Wang

view source

Location:

Shanghai City, China

Industry:

Biotechnology

Lawyers & Attorneys

Lixin Wang - Lawyer

view source

Address:

King & Wood Mallesons
(212)4126000 (Office)

Licenses:

New York - Currently registered 2008

Education:

New York University School of Law
Degree - JD

Specialties:

Mergers / Acquisitions - 34%
Securities / Investment Fraud - 33%
Real Estate - 33%

Us Patents

Surgical Compositions Containing Sigma-Receptor Agonists
view source
US Patent:

20110288101, Nov 24, 2011
Filed:

May 20, 2011
Appl. No.:

13/112827
Inventors:

Lixin Wang - Arlington TX, US
Marcia Danielle Ong - Fort Worth TX, US
Chi-Chun Tsai - Fort Worth TX, US
Michael Hartzer - Arlington TX, US
Assignee:

ALCON RESEARCH, LTD. - Fort Worth TX
International Classification:

A61K 31/439
C07C 211/28
A61K 31/137
C07C 251/58
A61P 41/00
C07D 307/14
A61K 31/341
C07D 295/096
A61K 31/495
A61P 27/02
C07D 221/26
A61K 31/15
US Classification:

51425212, 514295, 546 97, 564383, 514654, 564256, 514640, 549492, 514471, 544398
Abstract:

One aspect of the present invention relates to aqueous surgical compositions comprising a sigma-1 receptor agonist. Another aspect of the present invention relates to methods of irrigating ocular tissues during an ophthalmic surgical procedure such as cataract surgery. Such methods comprise bathing the ocular tissues with a composition comprising a sigma-1 receptor agonist.